DRAFT BHIVA GUIDELINES Routine monitoring of HIV UK-CAB 31 July 2009 Matt Williams writing committee community rep.

Slides:



Advertisements
Similar presentations
For primary and secondary care settings
Advertisements

HIV Counselling and Testing
Screening test of Pregnancy
Unit 6 Diagnosis & Follow-up of HIV Infection
HIV and Hep C testing Ardis Moe, M.D. UCLA CARE/NEVHC Van Nuys HIV Clinic Friday 20 June, 2014.
Tuberculosis in Children: Prevention Module 10C - March 2010.
Page Up to Reverse  Employee Health  Page Down to Advance  Employee Health 
HIV/AIDS Prevention and Treatment in Thailand
Acute Retroviral Syndrome
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Improving HIV case detection Steve Baguley Genitourinary physician, Aberdeen.
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Chronic diseases in HIV Francois Venter Wits Reproductive Health & HIV Institute
HIV Disease in Older Patients Donna M. Gallagher, ANP The International AIDS Society–USA DM Gallagher, ANP. Presented at IAS–USA/RWCA Clinical Conference,
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER 2014 IAS-USA Treatment Guidelines Brian R. Wood, MD Medical Director, NW AETC ECHO Assistant Professor.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
Hep 202 Just when you thought you knew everything.
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
+ Understanding HIV-Related Lab Tests Jordan E. Lake, MD, MSc AAHU August 27, 2014.
2 About HIV: Teaching Tool. About HIV: A teaching tool © 2nd edition 2006 This tool was developed by the François-Xavier Bagnoud Center at the University.
1. What is the most common mode of HIV transmission? 2. How else is HIV transmitted? 3. What is the most common mode of work related transmission? p.
Bloodborne Pathogens HIV, AIDS, and Hepatitis Unit 1.
An important message to blood donors Please read this BEFORE you donate blood.
Inputs to a case-based HIV surveillance system. Objectives  Review HIV case definitions  Understand clinical and immunologic staging  Identify the.
Guidance on Provider-initiated Voluntary Medical Examination, Testing and Counselling for Infectious Diseases in Injecting Drug Users Hans Blystad 1 and.
NYU Medical Grand Rounds Clinical Vignette Matthew B. Brown M.D. PGY-2 10/4/11 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
START study: UK-CAB July2015 Community feedback: START study Simon Collins HIV i-Base
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 First Clinic Visit for Patients with HIV Infection HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Marygrace Elson, MD, MME UIHC Department of Obstetrics and Gynecology.
BHIVA national clinical audit of ART Dr Margaret Johnson, Chair of BHIVA clinical audit committee Dr Gary Brook Vice-Chair of BHIVA clinical audit committee.
Antiretroviral Postexposure Prophylaxis after Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV in the United States Recommendations.
BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.
When to Initiate ART in Adults and Adolescents (2009 WHO Guidelines) Target PopulationClinical conditionRecommendation Asymptomatic Individuals (including.
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
Case 1: 23-year-old Male Student Clinical Director, Division of Infectious Diseases Brigham and Women’s Hospital Professor of Medicine Harvard Medical.
Mr X and Mr Y 1 Case 4: July year-old Caucasian man ‘Mr X’ 2.
BHIVA Audit Survey of patient assessment and monitoring Set-up phase of cohort audit of patients starting ART from naïve.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.
NURSETRI, Nursing role in HIV care : an overview Jane Bruton Clinical Research Nurse.
1 Monitoring The Patient on ARV Treatment HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Introduction to the.... HIV in the UK Over a quarter of those infected remain undiagnosed – HPA 35% of HIV-related deaths attributable to late diagnosis.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
+ Understanding HIV-Related Lab Tests Jordan E. Lake, MD, MSc AAHU Sept 1, 2015.
SPECIAL CONSIDERATIONS August
Blood Tests (“Labs”) 1. “Labs” Regular blood tests are a crucial part of HIV health care. They are often referred to as “bloods” or “labs” Several important.
SEXUAL HEALTH: SCREENING, VACCINES AND REFERRALS Dr Kate Morton.
1 Management, Care for infants who were born from infected mothers HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Human Immune Deficiency Virus Infection Dr Huda Taha Sep 2015.
Interventions for Clients with HIV/AIDS and Other Immunodeficiencies.
DR.S. MANSORI INFECTIOUS DISEASE SPECIALIST QAZVIN UNIVERCITY OF MEDICAL SCIENCE.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
1 Module 2: HIV Counseling and Testing for PMTCT Ministry of Health/HAPCO, Ethiopia.
Maternal Toxicity Management
How differentiated care supports “Tx all” and Dr
2017 Key Considerations for adolescents and children & Key populations
Maternal Toxicity Management
Module 4 (a) Getting started on PrEP
Maternal Toxicity Management
What’s New in the Perinatal Guidelines
Genetic Testing Result Means. Before Genetic Testing  The result of genetic testing can be life changing.  It is important for patients and their families.
PHARMACOTHERAPY III PHCY 510
Hepatitis B Hepatitis B is a pathogen, which causes liver disease and inflammation of the liver.
Just when you thought you knew everything.
Diagnosis and Management of Acute HIV
Presentation transcript:

DRAFT BHIVA GUIDELINES Routine monitoring of HIV UK-CAB 31 July 2009 Matt Williams writing committee community rep

DRAFT BHIVA GUIDELINES Routine monitoring of HIV First guideline of this kind Status: (soon-to-be published) draft for consultation Headlines: Long Confirms much current practice Some important new points

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Diagnosis recommended confirmed using 4 th generation tests (therefore all clinics should have access to 4 th generation tests) Window period: gone…

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! 4 th generation tests can detect HIV before seroconversion 6 week negative results for HIV antibody and antigen with no symptoms = does not have HIV

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Viral load cut-off: clinics must decide lower level for reporting “detectable” result Is it to be >40 copies/mL? >50? >100? Importance of viral load 50 noted VL in compartments not generally useful

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Viral load cut-off: some tests are very sensitive and report “mini-spikes” – in the 100s sometimes No firm recommendation on cut-off Clinics need to be aware of nature of, and ideally choose, viral load tests they use Paper forthcoming…

DRAFT BHIVA GUIDELINES Routine monitoring of HIV CURRENT CD4 (CD4%) and viral load every 3-4 months generally Every 6 months sometimes More often when starting/just started ARVs or otherwise needed Frequency by mutual agreement

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! CD4 – 2 baseline tests (diagnosis and first follow-up visit)?

DRAFT BHIVA GUIDELINES Routine monitoring of HIV CURRENT Resistance tests as soon as practical after diagnosis (genotype)

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Resistance tests at any viral load Comment on effectiveness of current assays at viral load <500 copies/mL (often works)

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Formalised comprehensive history at first visit, annual review Includes asking about mood and cognition Short form (2 question) format as per NICE guidelines Q: should mood and cognition be included at every clinic visit?

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Baseline assessment includes extensive screening for tropical diseases, including worms, TB, malaria and other infectious/parasitic agents Debate over measles immunity (current preference not to comment)

DRAFT BHIVA GUIDELINES Routine monitoring of HIV CURRENT STI screen: baseline and regularly

DRAFT BHIVA GUIDELINES Routine monitoring of HIV CURRENT Cholesterol and cardiovascular risk assessment: baseline and annual check

DRAFT BHIVA GUIDELINES Routine monitoring of HIV CURRENT Bone: baseline and annual metabolites (more often if over 50? smoker? on tenofovir) Vitamin D: noted (no recommendations on value of having a measure of deficiency)

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Bone: DEXA scan as per osteoporosis guidelines for general population at risk

DRAFT BHIVA GUIDELINES Routine monitoring of HIV CURRENT Liver enzymes: at every visit

DRAFT BHIVA GUIDELINES Routine monitoring of HIV CURRENT Hepatitis: baseline and annual check (A, B, C) Hepatitis A and B vaccination: recommended (check immunity)

DRAFT BHIVA GUIDELINES Routine monitoring of HIV CURRENT Urine protein: recommended (when?) Blood glucose: recommended (when? alternatives?) Full blood count: annual or more frequent Albumin: every visit TDM: as required

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Lipdystrophy, lipoatropy, metabolic syndrome, peripheral neuropathy: little comment, refer to (forthcoming) side effects and toxicity guidelines/other treatment guidelines

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Age: wrap-up comment on cardiovascular health, bone density and cognition (no special recommendations since no-one quite knows what to do)

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Phylogenetic testing: comment and overview of science Recommendation: no routine clinical use

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Phylogenetic testing is a research test used to show infection A relates genetically to infection B (as per criminal cases) What do people think?

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! STARHS (detecting recent infection): recommended as routine What do people think?

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NEW! Superinfection (reinfection): comment and overview of science If this occurs, not a useful indicator of a person’s sexual life (ie putting others at risk) What do people think?

DRAFT BHIVA GUIDELINES Routine monitoring of HIV UNSETTLED Pregnancy testing for women who may start/are on ARVs: offer? GP/HCW communication Some aspects of initial work-up Extra points for late diagnosis Adherence

DRAFT BHIVA GUIDELINES Routine monitoring of HIV NOT COVERED Patient communication People lost to follow-up Consent Pain Cancer screening (but no to routine HPV screening for men) What do people think?

DRAFT BHIVA GUIDELINES Routine monitoring of HIV ROADMAP Draft imminent 3 weeks BHIVA/UK-CAB advance consultation 3 weeks general consultation Final edit Publish in time for BHIVA autumn conference….